- Home
- EVAX vs ZCAR Comparison
EVAX vs ZCAR Comparison
Compare EVAX & ZCAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- ZCAR
- Stock Information
- Founded
- EVAX 2008
- ZCAR 2013
- Country
- EVAX Denmark
- ZCAR India
- Employees
- EVAX N/A
- ZCAR N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- ZCAR Blank Checks
- Sector
- EVAX Health Care
- ZCAR Finance
- Exchange
- EVAX Nasdaq
- ZCAR Nasdaq
- Market Cap
- EVAX 16.3M
- ZCAR 3.6M
- IPO Year
- EVAX 2021
- ZCAR N/A
- Fundamental
- Price
- EVAX $1.79
- ZCAR $0.28
- Analyst Decision
- EVAX Strong Buy
- ZCAR
- Analyst Count
- EVAX 3
- ZCAR 0
- Target Price
- EVAX $33.33
- ZCAR N/A
- AVG Volume (30 Days)
- EVAX 211.9K
- ZCAR 2.1M
- Earning Date
- EVAX 03-26-2025
- ZCAR 02-14-2025
- Dividend Yield
- EVAX N/A
- ZCAR N/A
- EPS Growth
- EVAX N/A
- ZCAR N/A
- EPS
- EVAX N/A
- ZCAR N/A
- Revenue
- EVAX $3,295,000.00
- ZCAR $9,117,419.00
- Revenue This Year
- EVAX $9,039.73
- ZCAR N/A
- Revenue Next Year
- EVAX $1.47
- ZCAR N/A
- P/E Ratio
- EVAX N/A
- ZCAR N/A
- Revenue Growth
- EVAX N/A
- ZCAR N/A
- 52 Week Low
- EVAX $1.70
- ZCAR $0.27
- 52 Week High
- EVAX $22.05
- ZCAR $183.00
- Technical
- Relative Strength Index (RSI)
- EVAX 35.07
- ZCAR 26.67
- Support Level
- EVAX $1.75
- ZCAR $0.32
- Resistance Level
- EVAX $1.99
- ZCAR $0.37
- Average True Range (ATR)
- EVAX 0.17
- ZCAR 0.06
- MACD
- EVAX 0.05
- ZCAR 0.03
- Stochastic Oscillator
- EVAX 10.70
- ZCAR 3.15
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About ZCAR Zoomcar Holdings Inc.
Zoomcar Holdings Inc is India's largest marketplace for cars on rent. Zoomcar is a leading emerging-market-focused peer-to-peer car-sharing marketplace, with approximately 21,000 vehicles registered through its platform. The Company derives its revenue principally from short-term self-drive rentals and vehicle subscriptions. The self-drive rental business generates the majority of revenue. Geographically The company operates in India, Egypt, Indonesia, Vietnam, and the Philippines, Out of which the majority of revenue is derived from India.